FLUOR-OP Drug Patent Profile
✉ Email this page to a colleague
When do Fluor-op patents expire, and what generic alternatives are available?
Fluor-op is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in FLUOR-OP is fluorometholone. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fluorometholone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluor-op
A generic version of FLUOR-OP was approved as fluorometholone by AMNEAL on January 9th, 2024.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUOR-OP?
- What are the global sales for FLUOR-OP?
- What is Average Wholesale Price for FLUOR-OP?
Summary for FLUOR-OP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 5,139 |
| DailyMed Link: | FLUOR-OP at DailyMed |
US Patents and Regulatory Information for FLUOR-OP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | FLUOR-OP | fluorometholone | SUSPENSION/DROPS;OPHTHALMIC | 070185-001 | Feb 27, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
